| Miss Elizabeth Clare Graham, FNP-C | |
|
3100 Channel Drive, Southeast Alaska Regional Health Consortium, Juneau, AK 99801-0000 | |
| (907) 463-4012 | |
| Not Available |
| Full Name | Miss Elizabeth Clare Graham |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 16 Years |
| Location | 3100 Channel Drive, Juneau, Alaska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003183252 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 609376 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Monument Health Rapid City Hospital | Rapid city, SD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pine Ridge Indian Health Service Hospital | 4688571326 | 93 |
News Archive
Elsevier, a world-leading publisher of scientific, technical and medical information products and services, is pleased to announce that as of January 2011 Elsevier will publish The Journal of Molecular Diagnostics (JMD) in partnership with the Association for Molecular Pathology (AMP) and the American Society for Investigative Pathology (ASIP).
With negotiations over the outcomes for the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) stalled, "[i]t is feared that sound proposals for clear goals and timelines to tackle these devastating diseases are being systematically deleted, diluted and downgraded by some U.N. Member States and urgent action is needed to put the negotiations back on track, when they recommence on September 1," Rob Moodie, chair of Global Health at the Nossal Institute of Global Health, writes in the Crikey health blog "Croakey."
Capstone Therapeutics announced today it has completed a limited analysis of a subset of data from its ongoing AZX100 Phase 2a clinical trial in trocar site scarring following arthroscopic shoulder surgery. Based on this analysis, the clinical trial will continue to its planned 12-month endpoints.
The Wall Street Journal writes how the health law's coverage expansions could provide entrepreneurs with a new source for health coverage.
National Jewish Health researchers have received nearly $13 million from the National Institutes of Health to evaluate potential rescue medications for victims of terrorist attacks, wartime use of toxic gases, and/or inhalation disasters. The gases of greatest interest in these studies will be 'mustard gas' (sulfur mustard) and chlorine gas.
› Verified 6 days ago
| Entity Name | Southeast Alaska Regional Health Consortium |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376758037 PECOS PAC ID: 1456265362 Enrollment ID: O20031114000631 |
News Archive
Elsevier, a world-leading publisher of scientific, technical and medical information products and services, is pleased to announce that as of January 2011 Elsevier will publish The Journal of Molecular Diagnostics (JMD) in partnership with the Association for Molecular Pathology (AMP) and the American Society for Investigative Pathology (ASIP).
With negotiations over the outcomes for the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) stalled, "[i]t is feared that sound proposals for clear goals and timelines to tackle these devastating diseases are being systematically deleted, diluted and downgraded by some U.N. Member States and urgent action is needed to put the negotiations back on track, when they recommence on September 1," Rob Moodie, chair of Global Health at the Nossal Institute of Global Health, writes in the Crikey health blog "Croakey."
Capstone Therapeutics announced today it has completed a limited analysis of a subset of data from its ongoing AZX100 Phase 2a clinical trial in trocar site scarring following arthroscopic shoulder surgery. Based on this analysis, the clinical trial will continue to its planned 12-month endpoints.
The Wall Street Journal writes how the health law's coverage expansions could provide entrepreneurs with a new source for health coverage.
National Jewish Health researchers have received nearly $13 million from the National Institutes of Health to evaluate potential rescue medications for victims of terrorist attacks, wartime use of toxic gases, and/or inhalation disasters. The gases of greatest interest in these studies will be 'mustard gas' (sulfur mustard) and chlorine gas.
› Verified 6 days ago
| Entity Name | Pine Ridge Indian Health Service Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497786412 PECOS PAC ID: 4688571326 Enrollment ID: O20031218000966 |
News Archive
Elsevier, a world-leading publisher of scientific, technical and medical information products and services, is pleased to announce that as of January 2011 Elsevier will publish The Journal of Molecular Diagnostics (JMD) in partnership with the Association for Molecular Pathology (AMP) and the American Society for Investigative Pathology (ASIP).
With negotiations over the outcomes for the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) stalled, "[i]t is feared that sound proposals for clear goals and timelines to tackle these devastating diseases are being systematically deleted, diluted and downgraded by some U.N. Member States and urgent action is needed to put the negotiations back on track, when they recommence on September 1," Rob Moodie, chair of Global Health at the Nossal Institute of Global Health, writes in the Crikey health blog "Croakey."
Capstone Therapeutics announced today it has completed a limited analysis of a subset of data from its ongoing AZX100 Phase 2a clinical trial in trocar site scarring following arthroscopic shoulder surgery. Based on this analysis, the clinical trial will continue to its planned 12-month endpoints.
The Wall Street Journal writes how the health law's coverage expansions could provide entrepreneurs with a new source for health coverage.
National Jewish Health researchers have received nearly $13 million from the National Institutes of Health to evaluate potential rescue medications for victims of terrorist attacks, wartime use of toxic gases, and/or inhalation disasters. The gases of greatest interest in these studies will be 'mustard gas' (sulfur mustard) and chlorine gas.
› Verified 6 days ago
| Entity Name | Anadarko Indian Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881637403 PECOS PAC ID: 7719931559 Enrollment ID: O20050304000365 |
News Archive
Elsevier, a world-leading publisher of scientific, technical and medical information products and services, is pleased to announce that as of January 2011 Elsevier will publish The Journal of Molecular Diagnostics (JMD) in partnership with the Association for Molecular Pathology (AMP) and the American Society for Investigative Pathology (ASIP).
With negotiations over the outcomes for the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) stalled, "[i]t is feared that sound proposals for clear goals and timelines to tackle these devastating diseases are being systematically deleted, diluted and downgraded by some U.N. Member States and urgent action is needed to put the negotiations back on track, when they recommence on September 1," Rob Moodie, chair of Global Health at the Nossal Institute of Global Health, writes in the Crikey health blog "Croakey."
Capstone Therapeutics announced today it has completed a limited analysis of a subset of data from its ongoing AZX100 Phase 2a clinical trial in trocar site scarring following arthroscopic shoulder surgery. Based on this analysis, the clinical trial will continue to its planned 12-month endpoints.
The Wall Street Journal writes how the health law's coverage expansions could provide entrepreneurs with a new source for health coverage.
National Jewish Health researchers have received nearly $13 million from the National Institutes of Health to evaluate potential rescue medications for victims of terrorist attacks, wartime use of toxic gases, and/or inhalation disasters. The gases of greatest interest in these studies will be 'mustard gas' (sulfur mustard) and chlorine gas.
› Verified 6 days ago
| Entity Name | Aleutian Pribilof Islands Association Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093939233 PECOS PAC ID: 0648310656 Enrollment ID: O20140225001523 |
News Archive
Elsevier, a world-leading publisher of scientific, technical and medical information products and services, is pleased to announce that as of January 2011 Elsevier will publish The Journal of Molecular Diagnostics (JMD) in partnership with the Association for Molecular Pathology (AMP) and the American Society for Investigative Pathology (ASIP).
With negotiations over the outcomes for the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) stalled, "[i]t is feared that sound proposals for clear goals and timelines to tackle these devastating diseases are being systematically deleted, diluted and downgraded by some U.N. Member States and urgent action is needed to put the negotiations back on track, when they recommence on September 1," Rob Moodie, chair of Global Health at the Nossal Institute of Global Health, writes in the Crikey health blog "Croakey."
Capstone Therapeutics announced today it has completed a limited analysis of a subset of data from its ongoing AZX100 Phase 2a clinical trial in trocar site scarring following arthroscopic shoulder surgery. Based on this analysis, the clinical trial will continue to its planned 12-month endpoints.
The Wall Street Journal writes how the health law's coverage expansions could provide entrepreneurs with a new source for health coverage.
National Jewish Health researchers have received nearly $13 million from the National Institutes of Health to evaluate potential rescue medications for victims of terrorist attacks, wartime use of toxic gases, and/or inhalation disasters. The gases of greatest interest in these studies will be 'mustard gas' (sulfur mustard) and chlorine gas.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miss Elizabeth Clare Graham, FNP-C 3100 Channel Dr, Southeast Alaska Regional Health Consortium, Juneau, AK 99801-7837 Ph: (805) 680-5185 | Miss Elizabeth Clare Graham, FNP-C 3100 Channel Drive, Southeast Alaska Regional Health Consortium, Juneau, AK 99801-0000 Ph: (907) 463-4012 |
News Archive
Elsevier, a world-leading publisher of scientific, technical and medical information products and services, is pleased to announce that as of January 2011 Elsevier will publish The Journal of Molecular Diagnostics (JMD) in partnership with the Association for Molecular Pathology (AMP) and the American Society for Investigative Pathology (ASIP).
With negotiations over the outcomes for the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) stalled, "[i]t is feared that sound proposals for clear goals and timelines to tackle these devastating diseases are being systematically deleted, diluted and downgraded by some U.N. Member States and urgent action is needed to put the negotiations back on track, when they recommence on September 1," Rob Moodie, chair of Global Health at the Nossal Institute of Global Health, writes in the Crikey health blog "Croakey."
Capstone Therapeutics announced today it has completed a limited analysis of a subset of data from its ongoing AZX100 Phase 2a clinical trial in trocar site scarring following arthroscopic shoulder surgery. Based on this analysis, the clinical trial will continue to its planned 12-month endpoints.
The Wall Street Journal writes how the health law's coverage expansions could provide entrepreneurs with a new source for health coverage.
National Jewish Health researchers have received nearly $13 million from the National Institutes of Health to evaluate potential rescue medications for victims of terrorist attacks, wartime use of toxic gases, and/or inhalation disasters. The gases of greatest interest in these studies will be 'mustard gas' (sulfur mustard) and chlorine gas.
› Verified 6 days ago
Miss Kaitlyn Bausler, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 641 W Willoughby Ave Ste 201, Juneau, AK 99801 Phone: 907-586-8100 | |
Sarah Elizabeth Lucas, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1701 Salmon Creek Ln, Juneau, AK 99801 Phone: 907-796-8774 Fax: 907-796-8728 | |
Bailey Alexandra Rahn, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1801 Salmon Creek Ln, Juneau, AK 99801 Phone: 907-586-2434 | |
Frances M Kinkead, CNM Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3412 Glacier Hwy, Juneau, AK 99801 Phone: 907-465-3353 | |
Ms. Merritt M Andruss, ANP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4675 Glacier Hwy, Juneau, AK 99801 Phone: 907-321-5708 Fax: 907-780-6425 | |
Karl Von Bausler, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3245 Hospital Dr, Juneau, AK 99801 Phone: 907-463-4000 Fax: 907-463-6663 |